1-4 of 4
Kun Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma

Deepti Telaraja, Yvette L. Kasamon, Justin S. Collazo, Ruby Leong, Kun Wang, Ping Li, Elyes Dahmane, Yuching Yang, Justin Earp, Manuela Grimstein, Lisa R. Rodriguez, Marc R. Theoret, Nicole J. Gormley
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 17–22.
https://doi.org/10.1158/1078-0432.CCR-23-1272
Published: 05 January 2024
View articletitled, FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Open the PDF for FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma in another window
Journal Articles

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

Xuyang Song, Robin Kate Kelley, Anis A. Khan, Nathan Standifer, Diansong Zhou, KyoungSoo Lim, Rajesh Krishna, Lu Liu, Kun Wang, Patricia McCoon, Alejandra Negro, Philip He, Megan Gibbs, John F. Kurland, Ghassan K. Abou-Alfa
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (4): 754–763.
https://doi.org/10.1158/1078-0432.CCR-22-1983
Published: 16 February 2023
View articletitled, Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
Open the PDF for Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study

Zhenyu Liu, Zhuolin Li, Jinrong Qu, Renzhi Zhang, Xuezhi Zhou, Longfei Li, Kai Sun, Zhenchao Tang, Hui Jiang, Hailiang Li, Qianqian Xiong, Yingying Ding, Xinming Zhao, Kun Wang, Zaiyi Liu, Jie Tian
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (12): 3538–3547.
https://doi.org/10.1158/1078-0432.CCR-18-3190
Published: 14 June 2019
View articletitled, Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study
Open the PDF for Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study in another window
Includes: Supplementary data
Journal Articles

A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy

Jiangdian Song, Jingyun Shi, Di Dong, Mengjie Fang, Wenzhao Zhong, Kun Wang, Ning Wu, Yanqi Huang, Zhenyu Liu, Yue Cheng, Yuncui Gan, Yongzhao Zhou, Ping Zhou, Bojiang Chen, Changhong Liang, Zaiyi Liu, Weimin Li, Jie Tian
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (15): 3583–3592.
https://doi.org/10.1158/1078-0432.CCR-17-2507
Published: 31 July 2018
View articletitled, A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
Open the PDF for A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy in another window
Includes: Supplementary data